1. Home
  2. SUZ vs ALGN Comparison

SUZ vs ALGN Comparison

Compare SUZ & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Suzano S.A.

SUZ

Suzano S.A.

HOLD

Current Price

$9.64

Market Cap

10.8B

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$172.69

Market Cap

12.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUZ
ALGN
Founded
1924
1997
Country
Brazil
United States
Employees
N/A
N/A
Industry
Paper
Industrial Specialties
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
12.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SUZ
ALGN
Price
$9.64
$172.69
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$179.09
AVG Volume (30 Days)
2.2M
929.4K
Earning Date
02-11-2026
02-04-2026
Dividend Yield
1.90%
N/A
EPS Growth
61.72
N/A
EPS
0.99
5.16
Revenue
$9,603,137,110.00
$3,982,622,000.00
Revenue This Year
$7.05
$2.58
Revenue Next Year
$12.79
$3.66
P/E Ratio
$9.73
$33.22
Revenue Growth
17.39
0.56
52 Week Low
$8.41
$122.00
52 Week High
$10.86
$237.23

Technical Indicators

Market Signals
Indicator
SUZ
ALGN
Relative Strength Index (RSI) 59.25 69.29
Support Level $9.52 $167.40
Resistance Level $9.81 $174.01
Average True Range (ATR) 0.15 4.19
MACD 0.03 0.41
Stochastic Oscillator 74.64 90.48

Price Performance

Historical Comparison
SUZ
ALGN

About SUZ Suzano S.A.

Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: